Hexarelin: 5mg

Europol Operation SHIELD VI (February 2026): Between April and November 2025, Europol coordinated Operation SHIELD VI — an international pharmaceutical crime enforcement operation across 30 countries resulting in 3,354 individuals prosecuted and €33 million (approx. $38.6M) in counterfeit medicines and illegal supplements seized, including peptides, doping agents, and anabolic compounds. Results announced February 25, 2026. This operation reinforces that cross-border sale of unregulated injectable compounds, including research peptides, is subject to active multi-jurisdictional enforcement. Sources: Europol press release (europol.europa.eu, February 25, 2026); OLAF; InsideTheGames (February 2026). INTERPOL Operation Pangea XVIII (March–May 2026): Between March 10 and 23, 2026, INTERPOL coordinated Operation Pangea XVIII across 90 countries and territories, targeting illicit pharmaceutical supply chains including online sellers of falsified medicines and unapproved injectables. In the UK alone, over two million doses of illicit medicines valued at £4.6 million were seized at the border. The Danish Medicines Agency reported six websites to police and detained 19 consignments. This operation specifically targeted online and social-media-driven sales of unapproved injectable products. Source: UK Government/MHRA (gov.uk, May 2026); Danish Medicines Agency (laegemiddelstyrelsen.dk, 2026); INTERPOL. Swissmedic / Basel-Landschaft Pratteln Seizure (October 7, 2026): On October 7, 2026, the Basel-Landschaft public prosecutor's office announced a criminal investigation after a September 2026 house search in Pratteln, Switzerland, seized more than 3,200 injection vials of illegally imported peptides plus syringes, packaging materials, and labels — described as the largest seizure of illegally imported peptides in Switzerland to date. Two individuals are under investigation for alleged violations of the Sport Promotion Act and the Therapeutic Products Act; the presumption of innocence applies. The case is linked to the June 22, 2026 cross-agency “Peptides 2026” campaign by Swissmedic, the Federal Office for Customs and Border Security (BAZG/FOCBS), and Swiss Sport Integrity (SSI), which inspected 46 packages of dubious peptide preparations (23 retained). Swiss authorities state that import of and trade in such unapproved injectable peptides is prohibited. Specific active ingredients in the Pratteln vials were not publicly named. This is Swiss domestic enforcement and does not change U.S. 503A/503B compounding status or FDA approval status of research peptides. Sources: Basel-Landschaft Staatsanwaltschaft media release (baselland.ch, 7 October 2026); Swiss federal press release on Peptides 2026 campaign (admin.ch, 30 June 2026); Swissinfo/Keystone-SDA (7 October 2026).